Middle East & Africa Transdermal Drug Delivery System Market
The Middle East & Africa Transdermal Drug Delivery System Market size was valued at US$ 1,147.56 Mn in 2022 and is projected to reach US$ 1,525.09 Mn by 2030, growing at a CAGR of 3.6% during 2022 - 2030.
Report Coverage
- Type: Transdermal Patches, Transdermal Gel, Transdermal Sprays
- Application: Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, Other Applications
- Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
US$ 1,147.56 Mn
Market size in 2022
US$ 1,525.09 Mn
Market Size by 2030
3.6%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Transdermal Drug Delivery System Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Transdermal Drug Delivery System Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Transdermal Drug Delivery System Market Regional Analysis
6.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Transdermal Drug Delivery System Market Forecast Analysis
7. Middle East & Africa Transdermal Drug Delivery System Market Analysis – by Type
7.1 Transdermal Patches
- 7.1.1 Overview
- 7.1.2 Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Transdermal Gel
- 7.2.1 Overview
- 7.2.2 Transdermal Gel: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Transdermal Sprays
- 7.3.1 Overview
- 7.3.2 Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Transdermal Drug Delivery System Market Analysis – by Application
8.1 Cardiovascular Diseases
- 8.1.1 Overview
- 8.1.2 Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Central Nervous System Disorders
- 8.2.1 Overview
- 8.2.2 Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Hormonal Applications
- 8.4.1 Overview
- 8.4.2 Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Other Applications
- 8.5.1 Overview
- 8.5.2 Other Applications: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Transdermal Drug Delivery System Market Analysis – by Distribution Channel
9.1 Hospitals Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospitals Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Online Pharmacies
- 9.3.1 Overview
- 9.3.2 Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa Transdermal Drug Delivery System Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.1.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.3.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
- 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GSK Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Hisamitsu Pharmaceutical Co Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Johnson & Johnson
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Novartis AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Viatris Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.